Tender Title: Dexamethasone Injection

Reference Number: GEM/2025/B/6145635

Issuing Authority/Department:
This tender is issued by the Department of Health Research, under the Ministry of Health and Family Welfare.

Scope of Work and Objectives

The purpose of this tender is to procure a total quantity of 5900 units of Dexamethasone Injection. Dexamethasone, a corticosteroid medication, is primarily used for its anti-inflammatory effects. This procurement aims to meet the healthcare needs across various healthcare facilities and support ongoing medical treatments. The objective is to ensure timely availability and supply of the medication to improve patient outcomes and support the healthcare infrastructure.

Eligibility Criteria

To participate in this tender, bidders must meet the following eligibility criteria:

• Be a registered entity under the applicable laws.
• Provide proof of capability to supply the specified quantity of Dexamethasone Injection.
• Previous experience in pharmaceutical procurement is desirable.
• Compliance with all relevant health and safety regulations.

Technical Requirements

All submissions must adhere to the following technical requirements:

• Quality standards compliant with national and international regulations.
• Documentation of quality assurance processes.
• Completed specifications detailing formulation, dosage, and packaging.
• Supporting evidence regarding expiration dates, shelf life, and storage conditions.

Financial Requirements

Bidders are required to submit comprehensive financial documents, including:

• A detailed pricing structure for the Dexamethasone Injection.
• Evidence of financial stability and capacity to fulfill the order.
• A declaration of compliance with pricing parameters set forth in government procurement guidelines.

Document Submission Details

Bidders must prepare and submit their bids in accordance with the following guidelines:

• All submissions should be made electronically via the official procurement portal.
• Essential documents include the technical proposal, financial bid, and eligibility documentation.
• Submissions must be clear, complete, and in the specified format outlined in the tender documents.

Special Provisions

This tender includes special provisions aimed at supporting Micro, Small, and Medium Enterprises (MSEs) and startups. These enterprises are encouraged to apply, and they may receive preferential treatment in the evaluation process. Participation in this tender also aligns with the 'Make in India' initiative to bolster local businesses and manufacturing capabilities.

Evaluation Process

The evaluation process for this tender will be conducted in a structured manner:

• Technical bids will be reviewed first for compliance with the technical requirements.
• Financial bids of those who meet the technical criteria will be opened for assessment.
• The bid with the best overall value, including quality, delivery time, and price, will be selected.

Delivery Locations

All supplies of the Dexamethasone Injection will need to be delivered to specified locations as outlined in the final contract, ensuring optimal accessibility to healthcare facilities.

Contact Information

For additional queries or specific clarifications, bidders may refer to the official contact details available on the procurement portal. All communication must be professional and directed accordingly to avoid misinterpretation.